Purchases and Sales Made in Q3 2023 in Relmada Therapeutics, Inc. (RLMD)
This table provides information about the institutional ownership of Relmada Therapeutics, Inc. (RLMD) during Q3 2023. The information is specifically focused on institutions that hold shares of RELMADA THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 26, 2023
Q3 2023
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-79.9K- 23.58% |
$198K - $303K
|
259K
$98.4K
|
|
|
Nov 14, 2023
Q3 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-81.3K- 33.09% |
$202K - $308K
|
164K
$62.5K
|
|
|
Nov 14, 2023
Q3 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-108K- 35.32% |
$267K - $408K
|
197K
$74.9K
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-149K- 91.99% |
$370K - $566K
|
13K
$4.94K
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-156K- 26.49% |
$386K - $590K
|
432K
$164K
|
|
|
Nov 09, 2023
Q3 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-233K- 97.92% |
$579K - $884K
|
4.96K
$1.88K
|